Login / Signup

The clinical signature of genetic variants and serum levels of macrophage migration inhibitory factor in Egyptian breast cancer patients.

Mahmoud A SeliemAhmed M MohamadinMohamed I Kotb El-SayedYahia IsmailAhmed A El-Husseiny
Published in: Breast cancer research and treatment (2024)
This study revealed that serum MIF levels may be regarded as a promising serum tumor marker for BC. Also, the rs1049829 variant of the MIF gene is considered a protective candidate against BC.
Keyphrases
  • adipose tissue
  • genome wide
  • single cell
  • gene expression